{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:31:55Z","timestamp":1779179515974,"version":"3.51.4"},"reference-count":255,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Coordination for the Enhancement of Higher Education (CAPES)"},{"name":"Foundation for the Support of Science and Technology in the State of Pernambuco (FACEPE)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bbcan.2013.12.004","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T10:01:35Z","timestamp":1388743295000},"page":"91-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Molecular targets of HPV oncoproteins: Potential biomarkers for cervical carcinogenesis"],"prefix":"10.1016","volume":"1845","author":[{"given":"Antonio Carlos","family":"de Freitas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane Campos","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria da Concei\u00e7\u00e3o Gomes","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2013.12.004_bb0005","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268805005728","article-title":"Vaccines for cervical cancer","volume":"134","author":"Lowndes","year":"2006","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0015","series-title":"Human Papillomavirus and Related Cancers in World Summary Report","article-title":"Information Centre on HPV and Cervical Cancer (HPV Information Centre)","author":"WHO\/ICO","year":"2010"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1345","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality","volume":"31","author":"Bosh","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0100-72032005000700010","article-title":"Neoplasia intra-epitelial cervical: diagn\u00f3stico e tratamento","volume":"27","author":"Derchain","year":"2005","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000335065","article-title":"Immunomarkers in gynecologic cytology: the search for the ideal biomolecular Papanicolaou test","volume":"56","author":"Pinto","year":"2012","journal-title":"Acta Cytol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0055","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","article-title":"Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis","volume":"92","author":"Hausen","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"ACS-ASCCP-ASCP Cervical Cancer Guideline Committee, American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0065","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/oxfordjournals.jncimonographs.a003473","article-title":"Genital human papillomavirus infection-current and prospective therapies","volume":"31","author":"Stanley","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0075","first-page":"1","article-title":"Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs","volume":"28","author":"Brown","year":"2012","journal-title":"J. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrc1010","article-title":"Translational approaches to improving cervical screening","volume":"3","author":"Baldwin","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cncr.23496","article-title":"Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology","volume":"114","author":"Beccati","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/dc.21164","article-title":"The use of p16 INK4A immunocytochemistry in \u2018Atypical squamous cells which cannot exclude HSIL\u2019 compared with \u2018Atypical squamous cells of undetermined significance\u2019 in liquid-based cervical smears","volume":"38","author":"Sung","year":"2010","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.mpdhp.2010.06.012","article-title":"Molecular markers of early cervical neoplasia","volume":"16","author":"Pinto","year":"2010","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/IGC.0b013e3182009eea","article-title":"The evaluation of p16INK4a immune expression\/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples","volume":"21","author":"Nasioutziki","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0105","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1158\/1078-0432.CCR-07-1231","article-title":"Altered MicroRNA expression in cervical carcinomas","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1261\/rna.1442309","article-title":"Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6","volume":"15","author":"Wang","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0115","doi-asserted-by":"crossref","first-page":"e11780","DOI":"10.1371\/journal.pone.0011780","article-title":"MicroRNA expression variability in human cervical tissues","volume":"5","author":"Pereira","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0120","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s12032-011-9830-2","article-title":"Aberrant MicroRNA expression in human cervical carcinomas","volume":"29","author":"Rao","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbagrm.2011.05.005","article-title":"Regulation of cellular miRNA expression by human papillomaviruses","volume":"1809","author":"Zheng","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0135","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","article-title":"Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival","volume":"64","author":"Takamizawa","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0140","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0150","first-page":"52","article-title":"The Therapeutic Potential of microRNAs","author":"Bader","year":"2011","journal-title":"Innov. Pharm. Technol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/viro.1995.0028","article-title":"Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions","volume":"214","author":"Haller","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2009.06.008","article-title":"Oncogenic activities of human papillomaviruses","volume":"143","author":"McLaughlin-Drubin","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0165","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1096\/fasebj.7.10.8393818","article-title":"Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes","volume":"7","author":"Vousden","year":"1993","journal-title":"Faseb J."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1634\/theoncologist.7-1-73","article-title":"Molecular aspects of the mammalian cell cycle and cancer","volume":"7","author":"Sandal","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0175","first-page":"286","article-title":"Cell intrinsic & extrinsic factors in cervical carcinogenesis","volume":"130","author":"Jayshree","year":"2009","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0180","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0185","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.2537532","article-title":"The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product","volume":"243","author":"Dyson","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virol.2003.11.008","article-title":"Molecular pathways executing the \u201ctrophic sentinel\u201d response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation","volume":"319","author":"Eichten","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3835(02)00431-7","article-title":"The role of human papillomavirus oncoproteins E6 and E7 in apoptosis","volume":"188","author":"Finzer","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0200","first-page":"9","article-title":"The role of human papilloma virus in the molecular biology of cervical carcinogenesis","volume":"50","author":"Motoyama","year":"2004","journal-title":"Kobe J. Med. Sci."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0205","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/01.LAB.0000092234.68751.83","article-title":"Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia","volume":"83","author":"Ueda","year":"2003","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910520202","article-title":"Second International Workshop on the epidemiology of cervical cancer and human papillomavirus","volume":"52","author":"Bosch","year":"1992","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0215","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/JVI.69.5.2989-2997.1995","article-title":"Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells","volume":"69","author":"Jeon","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2004.12.006","article-title":"The papillomavirus life cycle","volume":"32","author":"Doorbar","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0225","first-page":"7075","article-title":"The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability","volume":"62","author":"Duensing","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0230","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1038\/sj.onc.1210456","article-title":"Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templates","volume":"26","author":"Duensing","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0235","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.cdd.4401886","article-title":"Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis","volume":"13","author":"Garnett","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0240","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00705-006-0821-0","article-title":"Modulation of apoptosis by human papillomavirus (HPV) oncoproteins","volume":"151","author":"Garnett","year":"2006","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0245","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/j.1460-2075.1988.tb03013.x","article-title":"Comparison of the in vitro transforming activities of human papillomavirus types","volume":"7","author":"Storey","year":"1988","journal-title":"Embo J."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0255","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1038\/sj.onc.1204915","article-title":"Mechanisms of cell transformation by papillomavirus E5 proteins","volume":"20","author":"Dimaio","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1998.9227","article-title":"The E5 oncoprotein of human papillomavirus type 16 enhances endothelin-1-induced keratinocyte growth","volume":"248","author":"Venuti","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0265","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/carcin\/bgn236","article-title":"Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells","volume":"30","author":"Oh","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2010.01.009","article-title":"Gutierrez-Xicotencatl, The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1)","volume":"400","author":"Pedroza-Saavedra","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0275","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2005.09.112","article-title":"Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention","volume":"23","author":"Dannenberg","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1350","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0285","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/bjc.2012.109","article-title":"The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer","volume":"106","author":"Lajer","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0290","series-title":"Interplay Between HPV Oncoproteins and MicroRNAs in Cervical Cancer book","isbn-type":"print","author":"Reshmi","year":"2012","ISBN":"https:\/\/id.crossref.org\/isbn\/9789533078557"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0295","doi-asserted-by":"crossref","first-page":"e21646","DOI":"10.1371\/journal.pone.0021646","article-title":"Human papillomavirus 16 E5 modulates the expression of host microRNAs","volume":"6","author":"Greco","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-11-80","article-title":"Identification and validation of genes involved in cervical tumourigenesis","volume":"11","author":"Rajkumar","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/507286","article-title":"Biomarkers of cervical dysplasia and carcinoma","author":"wang","year":"2012","journal-title":"J. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0315","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/JVI.63.10.4417-4421.1989","article-title":"The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes","volume":"63","author":"Munger","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0325","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions","volume":"153","author":"Sano","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/viro.1994.1456","article-title":"The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression","volume":"203","author":"Bouvard","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0335","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1158\/0008-5472.CAN-05-0083","article-title":"Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogenes","volume":"65","author":"Williams","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0340","series-title":"Papillomavirus Research: From Natural History to Vaccines and Beyond","first-page":"97","article-title":"Biological activitites of papillomavirus E5 proteins","author":"Suprynowicz","year":"2006"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0345","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1128\/JVI.01032-12","article-title":"Quantitative measurement of human papillomavirus type 16 E5 oncoprotein levels in epithelial cell lines by mass spectrometry","volume":"86","author":"Sahab","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jmv.1890210202","article-title":"Presence of episomal and integrated human papilomavirus DNA sequences in cervical carcinoma","volume":"21","author":"Choo","year":"1987","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0355","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/JVI.65.2.606-612.1991","article-title":"Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm","volume":"65","author":"Cullen","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1365","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF02256414","article-title":"The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix","volume":"8","author":"Chang","year":"2001","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0365","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/sj.onc.1210791","article-title":"Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts","volume":"27","author":"Hafner","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0370","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/375506a0","article-title":"Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition","volume":"375","author":"Koh","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0375","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.93.9.4350","article-title":"Inhibition of cyclin D-CDK4\/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity","volume":"93","author":"Khleif","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0380","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri","volume":"92","author":"Klaes","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0385","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00479-7","article-title":"Expression of p16INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix","volume":"91","author":"Nieh","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0390","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/0DGGQBDQAMJCJBXB","article-title":"The predictive value of p16INK4a and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia","volume":"122","author":"Guo","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2004.11.034","article-title":"Is p16INK4A expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies","volume":"97","author":"Nieh","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0400","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0405","first-page":"13","article-title":"Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model","volume":"26","author":"Kruse","year":"2004","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0410","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/jcp.2005.027839","article-title":"Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers","volume":"59","author":"Baak","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0415","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH719>3.0.CO;2-E","article-title":"H. S. Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading","volume":"193","author":"Kruse","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0420","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.virol.2004.09.045","article-title":"Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy","volume":"331","author":"Santin","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0425","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2144\/05384SU03","article-title":"Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease","volume":"38","author":"Malinowski","year":"2005","journal-title":"Biotechniques"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0435","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.bi.56.070187.004313","article-title":"Receptors for epidermal growth factor and other polypeptide mitogens","volume":"56","author":"Carpenter","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1370","series-title":"Peptide Growth Factors and their Receptors","first-page":"69","article-title":"The epidermal growth factor family","author":"Carpenter","year":"1990"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0445","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/JVI.69.5.3185-3192.1995","article-title":"The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes","volume":"69","author":"Straight","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0455","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/excr.1998.4024","article-title":"The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT","volume":"241","author":"Crusius","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0460","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/0008-5472.CAN-05-3702","article-title":"Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence","volume":"66","author":"Chell","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0465","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.bcp.2010.07.013","article-title":"Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment","volume":"80","author":"Kim","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0470","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/JVI.70.11.7535-7539.1996","article-title":"Human papillomavirus type 11 and 16 E5 represses p21(WafI\/SdiI\/CipI) gene expression in fibroblasts and keratino-cytes","volume":"70","author":"Tsao","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0475","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0480","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI9621","article-title":"Host cyclooxygenase-2 modulated carcinoma growth","volume":"105","author":"Williams","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0485","first-page":"1679","article-title":"Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression","volume":"3","author":"Elder","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0490","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0495","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4143\/crt.2001.33.4.286","article-title":"Expression of cyclooxygenase-2 in human breast carcinoma: relevance to tumor angiogenesis and expression of estrogen receptor","volume":"33","author":"Kang","year":"2001","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0500","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1582-4934.2005.tb00379.x","article-title":"Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF)","volume":"9","author":"Byrne","year":"2005","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0505","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00018-005-5561-x","article-title":"Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor MEK\/ERK1,2 and PI3K\/Akt","volume":"63","author":"Kim","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0510","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/carcin\/bgp066","article-title":"Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein","volume":"30","author":"Kim","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0515","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0520","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0955-0674(96)80033-0","article-title":"Caveolae and caveolins","volume":"8","author":"Parton","year":"1996","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0525","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1128\/MCB.19.11.7289","article-title":"Caveolins, liquid-ordered domains, and signal transduction","volume":"19","author":"Smart","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0530","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1038\/sj.onc.1207911","article-title":"Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae","volume":"23","author":"Abulrob","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0535","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/neuonc\/nos079","article-title":"Caveolin-1, caveolae, and glioblastoma","volume":"14","author":"Parat","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0540","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0545","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ymeth.2012.08.002","article-title":"Functional validation of microRNA-target RNA interactions","volume":"58","author":"Vasudevan","year":"2012","journal-title":"Methods"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0550","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.gde.2005.06.012","article-title":"MicroRNAs in vertebrate development","volume":"15","author":"Harfe","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1375","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.jmb.2013.03.007","article-title":"The role of miRNAs regulating gene expression","volume":"425","author":"Gurtan","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1380","series-title":"Human Papillomavirus and Related Diseases\u2014From Bench to Bedside\u2014Research aspects","first-page":"349","article-title":"Interplay Between HPV Oncoproteins and MicroRNAs in Cervical Cancer","author":"Reshmi","year":"2012"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0570","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0575","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ceb.2009.03.002","article-title":"MicroRNAs and cancer\u2013new paradigms in molecular oncology","volume":"21","author":"Negrini","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0580","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/sj.onc.1210919","article-title":"Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells","volume":"27","author":"Martinez","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0585","doi-asserted-by":"crossref","first-page":"e2557","DOI":"10.1371\/journal.pone.0002557","article-title":"Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0590","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/IGC.0b013e3181d63170","article-title":"Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection","volume":"20","author":"Li","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0595","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network","volume":"447","author":"He","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0600","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","article-title":"Transcriptional activation of miR-34a contributes to p53-mediated apoptosis","volume":"26","author":"Raver-Shapira","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0605","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","article-title":"p53-mediated activation of miRNA34 candidate tumor-suppressor genes","volume":"17","author":"Bommer","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0610","doi-asserted-by":"crossref","first-page":"15472","DOI":"10.1073\/pnas.0707351104","article-title":"Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells","volume":"104","author":"Tazawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0615","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbadis.2011.09.018","article-title":"Lin, MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20","volume":"1822","author":"Yao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0620","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1128\/JVI.00078-10","article-title":"Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins","volume":"84","author":"Melar-New","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0625","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0630","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0635","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AOG.0b013e3181e4629f","article-title":"From human papillomavirus to cervical cancer","volume":"116","author":"Schiffman","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0640","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0645","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/dji186","article-title":"Human papilloma-virus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0650","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajog.2006.02.047","article-title":"Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)","volume":"195","author":"Walker","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0655","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/bjc.2012.489","article-title":"Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial\u2014the HPV FOCAL Study","volume":"107","author":"Ogilvie","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0660","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0665","first-page":"125","article-title":"Biomarcadores na triagem do c\u00e2ncer do colo uterino\/Biomarkers in cervical cancer screening DST","volume":"20","author":"Termini","year":"2008","journal-title":"J. bras Doen\u00e7as Sex Transm."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0670","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0675","series-title":"Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities","author":"Freeman","year":"2005"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0680","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0685","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","article-title":"p16 INK4a immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis","volume":"35","author":"Tsoumpou","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0690","doi-asserted-by":"crossref","first-page":"S547","DOI":"10.1007\/s12032-010-9705-y","article-title":"The study of the combination detection of HPV-DNA and p16INK4a in cervical Lesions","volume":"28","author":"Huang","year":"2011","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0695","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7314\/APJCP.2012.13.2.469","article-title":"p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies","volume":"13","author":"Cheah","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0700","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00292-011-1549-5","article-title":"Diagnosis and grading of cervical intraepithelial neoplasias","volume":"33","author":"Rosamilia","year":"2012","journal-title":"Pathologe"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0705","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3802\/jgo.2013.24.3.215","article-title":"p16INK4a immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J","volume":"24","author":"Nishio","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0710","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PGP.0b013e31826f5cf6","article-title":"Immunohistochemical Expression of Cyclin D1, p16Ink4a, p21WAF1, and Ki-67 Correlates With the Severity of Cervical Neoplasia","volume":"32","author":"Portari","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0715","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncy.21205","article-title":"p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis","volume":"120","author":"Roelens","year":"2012","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0720","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1159\/000338979","article-title":"Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program","volume":"56","author":"Gustinucci","year":"2012","journal-title":"Acta Cytol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0725","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/LGT.0b013e318215170c","article-title":"High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a","volume":"15","author":"Samir","year":"2011","journal-title":"J. Low Genit. Tract Dis."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0730","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/10520295.2011.637514","article-title":"AgNOR, p16 and human papillomavirus in low-grade squamous intra-epithelial lesions of the uterine cervix. Preliminary report","volume":"87","author":"Hidalgo","year":"2012","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0735","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.anndiagpath.2012.03.006","article-title":"P16INK4a imunocytochemistry\/immunohistochemistry: need for scoring uniformization to be clinically useful in gynecological pathology","volume":"16","author":"van Bogaert","year":"2012","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0740","first-page":"00319-9","article-title":"Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkers","volume":"S0301\u20132115","author":"Quint","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0750","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3349\/ymj.2005.46.5.597","article-title":"Aberrant cell cycle regulation in cervical carcinoma","volume":"46","author":"Kim","year":"2005","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0755","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00125480-200607000-00006","article-title":"p16INK4a immunoexpression: Surrogate markerof high-risk HPV and high-grade cervical intraepithelial neoplasia","volume":"13","author":"Kalof","year":"2006","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0760","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/CEJ.0b013e32833233d4","article-title":"Biomarkers in cervical screening: quantitative reverse transcriptase PCR analysis of P16INK4a expression","volume":"19","author":"Boulet","year":"2010","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0765","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/modpathol.2011.179","article-title":"p16INK4a and p14ARF mRNA expression in Pap smears is age-related","volume":"25","author":"von Keyserling","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0785","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1309\/0UP5PJK9RYF7BPHM","article-title":"Estimation of prognoses for Cervical Intraepithelial Neoplasia 2 by p16INK4a immunoexpression and High-Risk HPV In Situ Hybridization signal types","volume":"128","author":"Omori","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0790","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/PGP.0b013e31820a79b0","article-title":"Usefulness of p16INK4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri","volume":"30","author":"Negri","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0795","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.humpath.2010.10.021","article-title":"Biomarker expression in cervical intraepithelial neoplasia: potential progression predictive factors for low-grade lesions","volume":"42","author":"Ozaki","year":"2011","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0800","first-page":"428","article-title":"diagnostic value of P16 expression in premalignant and malignant cervical lesions","volume":"17","author":"Izadi-Mood","year":"2012","journal-title":"J. Res. Med Sci."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0805","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1083\/jcb.123.3.513","article-title":"The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins","volume":"123","author":"Schluter","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0810","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH719>3.0.CO;2-E","article-title":"The HS Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading","volume":"193","author":"Kruse","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0815","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/path.1316","article-title":"Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immunouantitative variables","volume":"199","author":"Kruse","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0820","first-page":"23","article-title":"Ki-67 expression in squamous intraepithelial lesions of the uterine cervix Arch","volume":"14","author":"Panjkovic","year":"2006","journal-title":"Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0825","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1309\/AJCPO0WY1VIFCYDC","article-title":"Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study","volume":"132","author":"Conesa-Zamora","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0830","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","article-title":"Using Biomarkers as Objective Standards in the Diagnosis of Cervical Biopsies","volume":"34","author":"Galgano","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0835","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/IGC.0b013e3181bc8da7","article-title":"Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection","volume":"20","author":"Mimica","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0840","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/path.998","article-title":"Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia","volume":"195","author":"Kruse","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0845","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00000478-200201000-00008","article-title":"Diagnostic accuracy of cervical low\u2010grade squamous intraepithelial lesions is improved with Ki\u201067 immunostaining","volume":"26","author":"Pirog","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0850","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jcp.56.9.681","article-title":"Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?","volume":"56","author":"Sahebali","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0855","first-page":"135","article-title":"The relationship between syntactic structure analysis features, histological grade and high\u2010risk HPV DNA in cervical intraepithelial neoplasia","volume":"26","author":"Kruse","year":"2004","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0860","first-page":"134","article-title":"Evaluation of prospective, routine application of Ki\u201067 immunoquantitation in early CIN for assessment of short\u2010term progression risk","volume":"26","author":"Kruse","year":"2004","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0865","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2012.05.004","article-title":"p16\/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy","volume":"126","author":"Don\u00e0","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0870","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","article-title":"p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study","volume":"119","author":"Schmidt","year":"2011","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0875","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0880","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cncy.20188","article-title":"Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2\/3 and AIS\/adenocarcinoma","volume":"120","author":"Singh","year":"2012","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0885","first-page":"822","article-title":"Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer","volume":"83","author":"Rokita","year":"2012","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0895","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncy.20061","article-title":"Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens","volume":"118","author":"Yu","year":"2010","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0900","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/PAI.0b013e3182167c66","article-title":"Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions","volume":"19","author":"Samarawardana","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0905","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s10439-011-0498-8","article-title":"Automated detection of dual p16\/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification","volume":"40","author":"Gertych","year":"2012","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0910","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/PAS.0b013e31815bbb69","article-title":"BDProExC: a sensitive and specific marker of HPV-associated squamous lesions of the cervix","volume":"32","author":"Badr","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0915","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/1055-9965.EPI-10-0818","article-title":"BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening","volume":"20","author":"Depuydt","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0920","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cncr.22171","article-title":"Validation of a novel immunocytochemical assay for topoisomerase II-\u03b1 and minichromosome maintenance protein 2 expression incervical cytology","volume":"108","author":"Shroyer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0925","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/cncr.22288","article-title":"Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay","volume":"108","author":"Kelly","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0930","doi-asserted-by":"crossref","first-page":"918","DOI":"10.5858\/2008-132-918-LCEOAN","article-title":"Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens","volume":"132","author":"Tambouret","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0935","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/dc.22944","article-title":"Performance of proex c and pretect hpv-proofer E6\/E7 mRNA tests in comparison with the hybrid capture 2 hpv dna test for triaging ASCUS and LSIL cytology","volume":"41","author":"Alaghehbandan","year":"2013","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0940","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.5858\/2008-132-1648-PCIAHH","article-title":"ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy","volume":"132","author":"Siddiqui","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0945","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PGP.0b013e3181895573","article-title":"A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-\u03b1 and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics","volume":"28","author":"Aximu","year":"2009","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0950","first-page":"387","article-title":"Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia","volume":"15","author":"Goto","year":"2006","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2013.12.004_bb1390","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1087057112459748","article-title":"High-Content Imaging in Cervical Cancer Screening","volume":"18","author":"Micalessi","year":"2013","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0960","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0965","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/1078-0432.CCR-0497-03","article-title":"Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival","volume":"10","author":"Kim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0970","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1002\/cncr.24364","article-title":"Novel chemotherapy approaches for cervical cancer","volume":"115","author":"Movva","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb0975","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdq723","article-title":"Epidermal growth factor receptor as a biomarker for cervical cancer","volume":"22","author":"Soonthornthum","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0980","first-page":"1187","article-title":"Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions","volume":"52","author":"Balan","year":"2011","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0985","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(97)00421-7","article-title":"Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer","volume":"123","author":"Scambia","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0990","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000050613","article-title":"Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis","volume":"22","author":"Ngan","year":"2001","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb0995","first-page":"3837","article-title":"Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes","volume":"61","author":"Akerman","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1000","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/modpathol.2010.239","article-title":"Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer","volume":"4","author":"Schrevel","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1005","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fj.00-0024com","article-title":"Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy","volume":"14","author":"Venuti","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1010","first-page":"6381","article-title":"Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade","volume":"62","author":"Bagnato","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1015","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-04-2661","article-title":"Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review","volume":"11","author":"Singhal","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1020","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.leukres.2005.04.023","article-title":"The conflicting roles of the cdk inhibitor p21(CIP1\/WAF1) in apoptosis","volume":"29","author":"Gartel","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1025","first-page":"578","article-title":"p53-independent expression of p21waf1\/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix","volume":"10","author":"Werness","year":"1997","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1030","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2409::AID-CNCR15>3.0.CO;2-T","article-title":"Expression of p21WAF1\/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis","volume":"82","author":"Lu","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.1999.5346","article-title":"Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas","volume":"73","author":"Skomedal","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004347-199901000-00002","article-title":"Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection","volume":"18","author":"Lie","year":"1999","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/gyno.2001.6397","article-title":"p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome","volume":"83","author":"Huang","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1055","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/1097-0142(20000915)89:6<1300::AID-CNCR15>3.0.CO;2-U","article-title":"Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses","volume":"89","author":"Giannoudis","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1006\/gyno.2002.6666","article-title":"Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms","volume":"85","author":"Huang","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1065","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ygyno.2003.12.008","article-title":"Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis","volume":"92","author":"Sgambato","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/IGC.0b013e318277edc8","article-title":"P27 as a prognostic factor of early cervical carcinoma","volume":"23","author":"Bouda","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1080","first-page":"429","article-title":"Cyclooxy-genase-2 is overexpressed in human cervical cancer","volume":"7","author":"Kulkarni","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygyno.2004.09.012","article-title":"Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays","volume":"97","author":"Kim","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ygyno.2006.03.036","article-title":"A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia","volume":"103","author":"Farley","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejogrb.2005.08.019","article-title":"The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II\u2013III phase II trial","volume":"125","author":"Hefler","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2009.04724.x","article-title":"Cyclooxygenase-2 expression in cervical intraepithelial neoplasia","volume":"1171","author":"Kim","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1105","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0360-3016(00)01583-2","article-title":"Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy","volume":"49","author":"Gaffney","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1110","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.20.4.973","article-title":"Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients","volume":"20","author":"Ferrandina","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1115","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ygyno.2007.07.023","article-title":"COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study","volume":"107","author":"Saldivar","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ijc.27686","article-title":"Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis","volume":"132","author":"Huang","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","article-title":"Vascular endothelial growth factor expression in early stage ovarian carcinoma","volume":"80","author":"Paley","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1130","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/bjc.1998.688","article-title":"Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer","volume":"78","author":"Ishigami","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1135","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0003-4975(99)00611-6","article-title":"Tumor angiogenesis and recurrence in stage I non-small cell lung cancer","volume":"68","author":"Ohta","year":"1999","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0029-7844(00)01025-5","article-title":"Vascular endothelial growth factor and prognosis of cervical carcinoma","volume":"96","author":"Cheng","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0090-8258(03)00224-5","article-title":"Expression of cyclooxygenase-1 and-2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes","volume":"90","author":"Kim","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1150","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/path.1467","article-title":"Expression of vascular endothelial growth factor (VEGF)\u2013C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis","volume":"201","author":"Van Trappen","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1155","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3346\/jkms.2004.19.5.693","article-title":"The prognostic effect of VEGF expression in squamous cell carcinoma of the cervix treated with radiation therapy alone","volume":"192","author":"Kang","year":"2004","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2004.12.020","article-title":"The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma","volume":"97","author":"Dai","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1165","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1170","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jcp.2005.026922","article-title":"HPV-Pathogen ISS Study Group, Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer","volume":"59","author":"Branca","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.critrevonc.2012.09.003","article-title":"Tissue biomarkers as prognostic variables of cervical cancer","volume":"86","author":"Gadducci","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2012.04.007","article-title":"Molecularly targeted therapies in cervical cancer. A systematic review","volume":"126","author":"Zagouri","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1190","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.onc.1210725","article-title":"HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells","volume":"27","author":"Suprynowicz","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1195","first-page":"1733","article-title":"Expression of Cav-1 in tumour cells, rather than in stromal tissue, may promote cervical squamous cell carcinoma proliferation, and correlates with high-risk HPV infection","volume":"27","author":"Sun","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1205","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-06-0561","article-title":"Patterns of known and novel small RNAs in human cervical cancer","volume":"67","author":"Lui","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/0008-5472.CAN-09-3289","article-title":"A microRNA expression signature for cervical cancer prognosis","volume":"70","author":"Hu","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2013.12.004_bb1395","first-page":"114","article-title":"MicroRNA Analysis in Human Papillomavirus (HPV)-Associated Cervical Neoplasia and Cancer","volume":"5","author":"McBee","year":"2011","journal-title":"J. Carcinog. Mutagen."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1225","doi-asserted-by":"crossref","first-page":"e28423","DOI":"10.1371\/journal.pone.0028423","article-title":"Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer","volume":"6","author":"Deftereos","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1400","first-page":"753","article-title":"miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2","volume":"5","author":"Liu","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1235","first-page":"357","article-title":"P53, p63 and Ki-67 assessment in HPV-induced cervical neoplasia","volume":"50","author":"Vasilescu","year":"2009","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/modpathol.2009.198","article-title":"P634A4 and TAp73 immunocytochemistry in liquid-based cervical cytology\u2014potential biomarkers for diagnosis and progress prediction of cervical neoplasia","volume":"23","author":"Cheung","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-59745-426-1_7","article-title":"DNA microchips to identify molecular signatures in cervical cancers","volume":"385","author":"Wong","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2009.02.011","article-title":"Epigenetic alterations in cervical carcinogenesis","volume":"19","author":"Szalmas","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-6-1","article-title":"Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data","volume":"6","author":"Yang","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5732\/cjc.012.10033","article-title":"Aberrant DNA methylation in cervical carcinogenesis","volume":"32","author":"Yang","year":"2013","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1270","doi-asserted-by":"crossref","first-page":"21.e1","DOI":"10.1016\/j.ajog.2010.07.036","article-title":"Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASCUS smear results","volume":"204","author":"Lin","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dc.21758","article-title":"Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1)","volume":"41","author":"Chao","year":"2011","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1280","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2010.10.029","article-title":"Detection of cervical neoplasia by DNA methylation analysis in cervico vaginal lavages, a feasibility study","volume":"120","author":"Eijsink","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1285","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ijc.25890","article-title":"Combined CADM1 and MAL promoter methylation analysis to detect (pre) malignant cervical lesions in high risk HPV positive women","volume":"129","author":"Overmeer","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1290","first-page":"121","article-title":"Quantitative analysis of the relationship between microRNA-124a, -34b and-203 gene methylation and cervical oncogenesis","volume":"4","author":"Botezatu","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1295","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1073\/pnas.93.1.479","article-title":"Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix","volume":"93","author":"Heselmeyer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1300","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/path.4168","article-title":"Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling","volume":"230","author":"Lando","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4161\/epi.24233","article-title":"Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer","volume":"8","author":"Senchenko","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.bbcan.2013.12.004_bb1310","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","article-title":"Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer","volume":"166","author":"Heselmeyer-Haddad","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1315","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2009.090122","article-title":"Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears","volume":"175","author":"Andersson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1405","doi-asserted-by":"crossref","first-page":"581.e1","DOI":"10.1016\/j.ajog.2009.12.016","article-title":"Amplification of the chromosome 3q26 region shows high negative predictive value for nonmalignant transformation of LSIL cytologic finding","volume":"202","author":"Jalali","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1325","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00439-012-1188-9","article-title":"Personalized medicine using DNA biomarkers: a review","volume":"131","author":"Ziegler","year":"2012","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1330","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2012.03.047","article-title":"Susceptibility to cervical cancer: an overview","volume":"126","author":"Freitas","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1335","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ygyno.2011.07.008","article-title":"New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil","volume":"123","author":"Chagas","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2013.12.004_bb1340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.meegid.2013.02.001","article-title":"Novel E6 and E7 oncogenes variants of Human Papillomavirus Type 31 in Brazilian Women with Abnormal Cervical Cytology","volume":"10","author":"Chagas","year":"2013","journal-title":"Infect. Genet. Evol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X13000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X13000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T13:41:22Z","timestamp":1716385282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X13000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":255,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0304419X13000632"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2013.12.004","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular targets of HPV oncoproteins: Potential biomarkers for cervical carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2013.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}